C. Manlius

557 total citations
13 papers, 433 citations indexed

About

C. Manlius is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, C. Manlius has authored 13 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in C. Manlius's work include Cancer Treatment and Pharmacology (9 papers), Advanced Breast Cancer Therapies (8 papers) and HER2/EGFR in Cancer Research (7 papers). C. Manlius is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Advanced Breast Cancer Therapies (8 papers) and HER2/EGFR in Cancer Research (7 papers). C. Manlius collaborates with scholars based in France, Switzerland and United States. C. Manlius's co-authors include Cristian Massacesi, Fabrice André, Mario Campone, Pabak Mukhopadhyay, Augustyn Bogucki, Luca Cariolato, Kurt Ballmer‐Hofer, Stéphanie Suarez, Michel Pieren and J M Wood and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

C. Manlius

13 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Manlius France 8 281 241 120 100 68 13 433
Manuela Gili Spain 4 328 1.2× 190 0.8× 106 0.9× 53 0.5× 54 0.8× 6 464
John O. DaSilva United States 8 274 1.0× 125 0.5× 92 0.8× 56 0.6× 37 0.5× 10 387
Yueyao Du China 17 240 0.9× 255 1.1× 115 1.0× 71 0.7× 247 3.6× 36 557
A M Gröger United States 6 273 1.0× 383 1.6× 99 0.8× 36 0.4× 60 0.9× 10 511
Tatsuya Hirai Japan 9 193 0.7× 263 1.1× 58 0.5× 26 0.3× 84 1.2× 13 494
Megan M. Starr United States 4 181 0.6× 180 0.7× 98 0.8× 57 0.6× 45 0.7× 4 335
Dao Doan United States 7 250 0.9× 179 0.7× 71 0.6× 21 0.2× 67 1.0× 11 437
Leland WK Chung United States 8 273 1.0× 180 0.7× 181 1.5× 33 0.3× 108 1.6× 14 427
Marcia R. Campbell United States 9 255 0.9× 343 1.4× 103 0.9× 210 2.1× 72 1.1× 10 512
Özge Alper United States 9 200 0.7× 180 0.7× 38 0.3× 67 0.7× 41 0.6× 12 365

Countries citing papers authored by C. Manlius

Since Specialization
Citations

This map shows the geographic impact of C. Manlius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Manlius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Manlius more than expected).

Fields of papers citing papers by C. Manlius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Manlius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Manlius. The network helps show where C. Manlius may publish in the future.

Co-authorship network of co-authors of C. Manlius

This figure shows the co-authorship network connecting the top 25 collaborators of C. Manlius. A scholar is included among the top collaborators of C. Manlius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Manlius. C. Manlius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
André, Fabrice, Mario Campone, Ruth O’Regan, et al.. (2010). Phase I Study of Everolimus Plus Weekly Paclitaxel and Trastuzumab in Patients With Metastatic Breast Cancer Pretreated With Trastuzumab. Journal of Clinical Oncology. 28(34). 5110–5115. 148 indexed citations
3.
Campone, Mario, Lorenzo Gianni, Cristian Massacesi, et al.. (2010). 436 Trastuzumab- (H) and everolimus- (RAD001) containing regimens are safe and active when reintroduced in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC) pre-treated with lapatinib. European Journal of Cancer Supplements. 8(3). 186–186. 6 indexed citations
4.
5.
6.
7.
8.
9.
10.
Jérusalem, Guy, Susan Ellard, Angelica Fasolo, et al.. (2009). Non-Infectious Pneumonitis (NIP) in Breast Cancer (BC) Patients (Pts) Treated with Everolimus (Afinitor™) Containing Therapy: Analysis of Five Studies.. Cancer Research. 69(24_Supplement). 1115–1115. 5 indexed citations
11.
12.
Jérusalem, Guy, Véronique Dièras, Fátima Cardoso, et al.. (2008). Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab. Journal of Clinical Oncology. 26(15_suppl). 1057–1057. 17 indexed citations
13.
Suarez, Stéphanie, Michel Pieren, Luca Cariolato, et al.. (2006). A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2. Cellular and Molecular Life Sciences. 63(17). 2067–2077. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuela Gili Breakdown of academic impact, for papers by John O. DaSilva Breakdown of academic impact, for papers by Yueyao Du Breakdown of academic impact, for papers by A M Gröger Breakdown of academic impact, for papers by Tatsuya Hirai Breakdown of academic impact, for papers by Megan M. Starr Breakdown of academic impact, for papers by Dao Doan Breakdown of academic impact, for papers by Leland WK Chung Breakdown of academic impact, for papers by Marcia R. Campbell Breakdown of academic impact, for papers by Özge Alper
Rankless by CCL
2026